Reference
Ward J, et al. Adalimumab-Induced Epstein-Barr Virus-Related Lymphoproliferative Disorder on FDG PET/CT. Clinical Nuclear Medicine 43: 344-345, No. 5, May 2018. Available from: URL: http://doi.org/10.1097/RLU.0000000000002054 - United Kingdom
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1704, 16 (2018). https://doi.org/10.1007/s40278-018-46659-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-46659-7